TAER-TAB
Tumor Associated Essential Receptor Targeting Antibody

Multifunctional Antibody Platform Technology

Huge Unmet Needs in Oncology

High Rate of Mutations in Cancers Results in Patients that are Drug Resistant or Refractory​

NUMBER OF MUTATIONS PER TUMOR

OUR SOLUTION

TAER-TAB is a platform technology that can be used to create multifunctional antibodies directed against multiple receptor targets on cancer cells. Multifunctional antibodies, such as Bispecifics, provide the dual benefits of Targeted Therapy and Immune Therapy.